Published in Pharmacol Ther on March 04, 2010
Role for miR-204 in human pulmonary arterial hypertension. J Exp Med (2011) 2.60
Pulmonary arterial hypertension: basis of sex differences in incidence and treatment response. Br J Pharmacol (2014) 0.97
Signal transduction in the development of pulmonary arterial hypertension. Pulm Circ (2013) 0.95
Krüppel-like factor 5 contributes to pulmonary artery smooth muscle proliferation and resistance to apoptosis in human pulmonary arterial hypertension. Respir Res (2011) 0.95
Eosinophils are necessary for pulmonary arterial remodeling in a mouse model of eosinophilic inflammation-induced pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol (2011) 0.83
Pulse Wave Velocity in Postmenopausal Women. Pulse (Basel) (2013) 0.75
Dehydroepiandrosterone sulfate as a risk factor for premature myocardial infarction: a comparative study. Korean J Fam Med (2015) 0.75
Role for miR-204 in human pulmonary arterial hypertension. J Exp Med (2011) 2.60
The role of Nogo and the mitochondria-endoplasmic reticulum unit in pulmonary hypertension. Sci Transl Med (2011) 1.95
Impaired angiogenesis and peripheral muscle microcirculation loss contribute to exercise intolerance in pulmonary arterial hypertension. Am J Respir Crit Care Med (2014) 1.59
Pyruvate dehydrogenase inhibition by the inflammatory cytokine TNFα contributes to the pathogenesis of pulmonary arterial hypertension. J Mol Med (Berl) (2011) 1.56
Targeting cell motility in pulmonary arterial hypertension. Eur Respir J (2013) 1.47
Role of reactive oxygen species and gp91phox in endothelial dysfunction of pulmonary arteries induced by chronic hypoxia. Br J Pharmacol (2006) 1.35
Signal transducers and activators of transcription-3/pim1 axis plays a critical role in the pathogenesis of human pulmonary arterial hypertension. Circulation (2011) 1.33
Air pollutant emissions from rice straw open field burning in India, Thailand and the Philippines. Environ Pollut (2009) 1.32
Dehydroepiandrosterone (DHEA) prevents and reverses chronic hypoxic pulmonary hypertension. Proc Natl Acad Sci U S A (2003) 1.13
In vivo and in vitro effects of Bidens pilosa L. (Asteraceae) leaf aqueous and ethanol extracts on primed-oestrogenized rat uterine muscle. Afr J Tradit Complement Altern Med (2007) 1.11
Role for DNA damage signaling in pulmonary arterial hypertension. Circulation (2013) 1.11
Circulating microparticles from pulmonary hypertensive rats induce endothelial dysfunction. Am J Respir Crit Care Med (2010) 1.07
Dehydroepiandrosterone inhibits the Src/STAT3 constitutive activation in pulmonary arterial hypertension. Am J Physiol Heart Circ Physiol (2011) 1.05
STAT3 signaling in pulmonary arterial hypertension. JAKSTAT (2012) 1.04
5-HT induces an arachidonic acid-sensitive calcium influx in rat small intrapulmonary artery. Am J Physiol Lung Cell Mol Physiol (2004) 0.99
Time course of differential mitochondrial energy metabolism adaptation to chronic hypoxia in right and left ventricles. Cardiovasc Res (2005) 0.96
Involvement of TRPV1 and TRPV4 channels in migration of rat pulmonary arterial smooth muscle cells. Pflugers Arch (2012) 0.96
Effect of chronic hypoxia on voltage-independent calcium influx activated by 5-HT in rat intrapulmonary arteries. Pflugers Arch (2006) 0.96
Discovery of benzylidenebenzofuran-3(2H)-one (aurones) as inhibitors of tyrosinase derived from human melanocytes. J Med Chem (2006) 0.95
Krüppel-like factor 5 contributes to pulmonary artery smooth muscle proliferation and resistance to apoptosis in human pulmonary arterial hypertension. Respir Res (2011) 0.95
HIF-1 inhibition decreases systemic vascular remodelling diseases by promoting apoptosis through a hexokinase 2-dependent mechanism. Cardiovasc Res (2010) 0.95
Signal transduction in the development of pulmonary arterial hypertension. Pulm Circ (2013) 0.95
Expression and physiological roles of TRP channels in smooth muscle cells. Adv Exp Med Biol (2011) 0.94
RAGE-dependent activation of the oncoprotein Pim1 plays a critical role in systemic vascular remodeling processes. Arterioscler Thromb Vasc Biol (2011) 0.93
Voltage-independent calcium influx in smooth muscle. Prog Biophys Mol Biol (2008) 0.91
Vascular smooth muscle modulates endothelial control of vasoreactivity via reactive oxygen species production through myoendothelial communications. PLoS One (2009) 0.91
Sildenafil alters calcium signaling and vascular tone in pulmonary arteries from chronically hypoxic rats. Am J Physiol Lung Cell Mol Physiol (2004) 0.91
Modulation of ion channels in pulmonary arterial hypertension. Curr Pharm Des (2007) 0.89
Critical role for the advanced glycation end-products receptor in pulmonary arterial hypertension etiology. J Am Heart Assoc (2013) 0.88
Chronic hypoxia induces nonreversible right ventricle dysfunction and dysplasia in rats. Am J Physiol Heart Circ Physiol (2004) 0.86
Reversal of chronic hypoxia-induced alterations in pulmonary artery smooth muscle electromechanical coupling upon air breathing. Cardiovasc Res (2002) 0.86
Serotonin-induced activation of TRPV4-like current in rat intrapulmonary arterial smooth muscle cells. Cell Calcium (2007) 0.86
Effect of pulmonary arterial hypertension-specific therapies on health-related quality of life: a systematic review. Chest (2014) 0.84
From oncoproteins/tumor suppressors to microRNAs, the newest therapeutic targets for pulmonary arterial hypertension. J Mol Med (Berl) (2011) 0.84
Role of the gap junctions in the contractile response to agonists in pulmonary artery from two rat models of pulmonary hypertension. Respir Res (2011) 0.83
Biopterin metabolism and eNOS expression during hypoxic pulmonary hypertension in mice. PLoS One (2013) 0.83
Tumor necrosis factor inhibitors as novel therapeutic tools for vascular remodeling diseases. Am J Physiol Heart Circ Physiol (2010) 0.83
MicroRNA networks in pulmonary arterial hypertension: share mechanisms with cancer? Curr Opin Oncol (2016) 0.82
Stretch-activated channels in pulmonary arterial smooth muscle cells from normoxic and chronically hypoxic rats. Cell Calcium (2010) 0.82
Dehydroepiandrosterone reverses chronic hypoxia/reoxygenation-induced right ventricular dysfunction in rats. Eur Respir J (2012) 0.82
Analogues of N-hydroxycinnamoylphenalkylamides as inhibitors of human melanocyte-tyrosinase. Bioorg Med Chem Lett (2006) 0.82
Role of Ca(2+)-sensitive K(+) channels in the remission phase of pulmonary hypertension in chronic obstructive pulmonary diseases. Cardiovasc Res (2003) 0.82
Plumbagin reverses proliferation and resistance to apoptosis in experimental PAH. Eur Respir J (2012) 0.82
Pim-1: A new biomarker in pulmonary arterial hypertension. Pulm Circ (2013) 0.81
Repeatability and responsiveness of exercise tests in pulmonary arterial hypertension. Eur Respir J (2012) 0.80
Reactive oxygen species as therapeutic targets in pulmonary hypertension. Ther Adv Respir Dis (2013) 0.80
Dehydroepiandrosterone (DHEA) improves pulmonary hypertension in chronic obstructive pulmonary disease (COPD): a pilot study. Ann Endocrinol (Paris) (2012) 0.80
Today's and tomorrow's imaging and circulating biomarkers for pulmonary arterial hypertension. Cell Mol Life Sci (2012) 0.79
Implication of the ryanodine receptor in TRPV4-induced calcium response in pulmonary arterial smooth muscle cells from normoxic and chronically hypoxic rats. Am J Physiol Lung Cell Mol Physiol (2012) 0.79
Beneficial effect of dehydroepiandrosterone on pulmonary hypertension in a rodent model of pulmonary hypertension in infants. Pediatr Res (2013) 0.78
Skeletal muscle proteomic signature and metabolic impairment in pulmonary hypertension. J Mol Med (Berl) (2014) 0.78
Is the translocon a crucial player of the calcium homeostasis in vascular smooth muscle cell? Am J Physiol Heart Circ Physiol (2009) 0.77
Chronic hypoxia-induced alterations in mitochondrial energy metabolism are not reversible in rat heart ventricles. Can J Physiol Pharmacol (2011) 0.77
Impaired Skeletal Muscle Oxygenation and Exercise Tolerance in Pulmonary Hypertension. Med Sci Sports Exerc (2015) 0.77
Characterization of the components of urban particulate matter mediating impairment of nitric oxide-dependent relaxation in intrapulmonary arteries. J Appl Toxicol (2013) 0.76
The emergence of new therapeutic targets in pulmonary arterial hypertension: from now to the near future. Expert Rev Respir Med (2013) 0.76
Anti-inflammatory and immunosuppressive agents in PAH. Handb Exp Pharmacol (2013) 0.75
Framework for life cycle sustainability assessment of municipal solid waste management systems with an application to a case study in Thailand. Waste Manag Res (2012) 0.75